Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Contribution of the infection-associated complement regulator-acquiring surface protein 4 (ErpC) to complement resistance of Borrelia burgdorferi.

Hammerschmidt C, Hallström T, Skerka C, Wallich R, Stevenson B, Zipfel PF, Kraiczy P.

Clin Dev Immunol. 2012;2012:349657. doi: 10.1155/2012/349657. Epub 2012 Jan 30.

2.

Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.

Siegel C, Hallström T, Skerka C, Eberhardt H, Uzonyi B, Beckhaus T, Karas M, Wallich R, Stevenson B, Zipfel PF, Kraiczy P.

PLoS One. 2010 Oct 20;5(10):e13519. doi: 10.1371/journal.pone.0013519.

3.

Immunological characterization of the complement regulator factor H-binding CRASP and Erp proteins of Borrelia burgdorferi.

Kraiczy P, Hartmann K, Hellwage J, Skerka C, Kirschfink M, Brade V, Zipfel PF, Wallich R, Stevenson B.

Int J Med Microbiol. 2004 Apr;293 Suppl 37:152-7.

PMID:
15146998
4.

Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.

Kraiczy P, Skerka C, Brade V, Zipfel PF.

Infect Immun. 2001 Dec;69(12):7800-9.

5.

Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi.

Brooks CS, Vuppala SR, Jett AM, Alitalo A, Meri S, Akins DR.

J Immunol. 2005 Sep 1;175(5):3299-308.

6.

Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1.

Siegel C, Schreiber J, Haupt K, Skerka C, Brade V, Simon MM, Stevenson B, Wallich R, Zipfel PF, Kraiczy P.

J Biol Chem. 2008 Dec 12;283(50):34855-63. doi: 10.1074/jbc.M805844200. Epub 2008 Sep 29.

7.

Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins.

Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, Simon MM, Brade V, Zipfel PF, Wallich R.

J Biol Chem. 2004 Jan 23;279(4):2421-9. Epub 2003 Nov 7.

8.

Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.

Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V.

Int J Med Microbiol. 2002 Jun;291 Suppl 33:141-6. Review.

PMID:
12141738
9.

Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1.

Hartmann K, Corvey C, Skerka C, Kirschfink M, Karas M, Brade V, Miller JC, Stevenson B, Wallich R, Zipfel PF, Kraiczy P.

Mol Microbiol. 2006 Sep;61(5):1220-36.

10.

Identification and functional characterization of complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes Borrelia afzelii and Borrelia garinii.

Wallich R, Pattathu J, Kitiratschky V, Brenner C, Zipfel PF, Brade V, Simon MM, Kraiczy P.

Infect Immun. 2005 Apr;73(4):2351-9.

11.

Complement regulator-acquiring surface proteins of Borrelia burgdorferi: a new protein family involved in complement resistance.

Kraiczy P, Skerka C, Zipfel PF, Brade V.

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):568-73. Review.

PMID:
12422603
12.

Binding of human complement regulators FHL-1 and factor H to CRASP-1 orthologs of Borrelia burgdorferi.

Kraiczy P, Rossmann E, Brade V, Simon MM, Skerka C, Zipfel PF, Wallich R.

Wien Klin Wochenschr. 2006 Nov;118(21-22):669-76.

PMID:
17160605
13.

Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H.

Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel PF.

Eur J Immunol. 2001 Jun;31(6):1674-84.

14.
15.

Binding of human factor H-related protein 1 to serum-resistant Borrelia burgdorferi is mediated by borrelial complement regulator-acquiring surface proteins.

Haupt K, Kraiczy P, Wallich R, Brade V, Skerka C, Zipfel PF.

J Infect Dis. 2007 Jul 1;196(1):124-33. Epub 2007 May 23.

PMID:
17538892
16.

CspA from Borrelia burgdorferi inhibits the terminal complement pathway.

Hallström T, Siegel C, Mörgelin M, Kraiczy P, Skerka C, Zipfel PF.

MBio. 2013 Aug 13;4(4). pii: e00481-13. doi: 10.1128/mBio.00481-13.

17.

Borrelia burgdorferi regulates expression of complement regulator-acquiring surface protein 1 during the mammal-tick infection cycle.

von Lackum K, Miller JC, Bykowski T, Riley SP, Woodman ME, Brade V, Kraiczy P, Stevenson B, Wallich R.

Infect Immun. 2005 Nov;73(11):7398-405.

18.

Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.

Hammerschmidt C, Koenigs A, Siegel C, Hallström T, Skerka C, Wallich R, Zipfel PF, Kraiczy P.

Infect Immun. 2014 Jan;82(1):380-92. doi: 10.1128/IAI.01094-13. Epub 2013 Nov 4.

19.

The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the lyme disease spirochete.

Kenedy MR, Akins DR.

Infect Immun. 2011 Apr;79(4):1451-7. doi: 10.1128/IAI.01274-10. Epub 2011 Jan 31.

20.

Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates.

Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V.

Int Immunopharmacol. 2001 Mar;1(3):393-401. Review.

PMID:
11367524

Supplemental Content

Support Center